Fidea Capital, Ltd.

Overview

Fidea Capital, Ltd. is a Japanese venture capital firm based in Yamagata, Japan, specializing in early-stage investments within the biotechnology sector. The firm focuses on providing financial support to emerging companies in areas such as pharmaceuticals, medical devices, digital health, and healthcare services. Fidea Capital aims to foster innovation and growth in Japan's biotech industry by partnering with promising startups and offering strategic guidance. The firm's investment strategy encompasses a wide range of stages, including early-stage, Series A, Series B, growth, late-stage, pre-IPO, buyout, turnaround, and distressed investments. This comprehensive approach allows Fidea Capital to support companies at various points in their development, from inception to expansion. By leveraging its expertise and network, the firm seeks to enhance the value and success of its portfolio companies. Fidea Capital's commitment to the biotechnology sector is demonstrated through its active participation in significant funding rounds. Notably, the firm was involved in a third-party allocation of new shares to J-Pharma Co., Ltd. in July 2020, contributing to a total financing of 1,746 million yen. This investment underscores Fidea Capital's dedication to advancing medical research and development in Japan, particularly in the field of cancer therapy. Through such strategic investments, Fidea Capital continues to play a pivotal role in shaping the future of Japan's biotechnology landscape.

Investment Focus

• Early-stage biotechnology companies in Japan seeking growth capital

Portfolio Companies